A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This is a two-part multiple dose study in healthy male and female (of non-child bearing
potential) elderly volunteers, and in Alzheimer's disease patients, to assess the safety,
effects on the body, and blood, CSF, and urine drug levels of AZD3293. AZD3293 is being
developed for the treatment of Alzheimer's Disease